Literature DB >> 16950552

Seizure following sudden zolpidem withdrawal.

Wiesław J Cubała1, Jerzy Landowski.   

Abstract

Zolpidem is a short acting hypnotic drug belonging to imidazopyridine family. It produces its hypnotic effects via the GABA-A benzodiazepine receptor complex, and binds preferentially to those receptors containing the alpha-1 subunit. In comparison with benzodiazepines this mechanism is thought to reduce liability to induce dependence. Several case reports of zolpidem abuse and dependence have been published along with a small number of cases demonstrating seizures after sudden zolpidem withdrawal. We describe a case of a 29-year-old Caucasian woman who developed a generalized seizure following sudden zolpidem withdrawal subsequent to drug dependence to 160mg of zolpidem. The clinical effects of zolpidem seem to be comparable to those of benzodiazepines and abuse, dependence and withdrawal seizures belong to the spectrum of its adverse drug reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950552     DOI: 10.1016/j.pnpbp.2006.07.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  13 in total

1.  Adverse reactions to zolpidem: case reports and a review of the literature.

Authors:  Takuji Inagaki; Tsuyoshi Miyaoka; Seiichi Tsuji; Yasushi Inami; Akira Nishida; Jun Horiguchi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects.

Authors:  Wiesław J Cubała; Jerzy Landowski; Hubert M Wichowicz
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

Review 3.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

4.  The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial.

Authors:  Marc Tompkins; Matthew Plante; Keith Monchik; Braden Fleming; Paul Fadale
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-21       Impact factor: 4.342

5.  Modest abuse-related subjective effects of zolpidem in drug-naive volunteers.

Authors:  Stephanie C Licata; Yasmin Mashhoon; Robert R Maclean; Scott E Lukas
Journal:  Behav Pharmacol       Date:  2011-04       Impact factor: 2.293

Review 6.  Zolpidem: Efficacy and Side Effects for Insomnia.

Authors:  Amber N Edinoff; Natalie Wu; Yahya T Ghaffar; Rosemary Prejean; Rachel Gremillion; Mark Cogburn; Azem A Chami; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-18

7.  Pharmacoepidemiological characterisation of zolpidem and zopiclone usage.

Authors:  Caroline Victorri-Vigneau; F Feuillet; L Wainstein; M Grall-Bronnec; J Pivette; A Chaslerie; V Sébille; P Jolliet
Journal:  Eur J Clin Pharmacol       Date:  2013-07-23       Impact factor: 2.953

8.  The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.

Authors:  Brittany T Wright; Catherine F Gluszek; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-15       Impact factor: 4.530

9.  Effect of a sleep aid in analgesia after arthroscopic rotator cuff repair.

Authors:  Chul-Hyun Cho; Si-Wook Lee; Young-Kuk Lee; Hong-Kwan Shin; Ilseon Hwang
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

10.  Zolpidem dependency and withdrawal seizure: a case report study.

Authors:  Seyed Alireza Haji Seyed Javadi; Farid Hajiali; Marjan Nassiri-Asl
Journal:  Iran Red Crescent Med J       Date:  2014-11-11       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.